_version_ 1783522199229956096
author Mina, Roberto
Joseph, Nisha S.
Gay, Francesca
Kastritis, Efstathios
Petrucci, Maria Teresa
Kaufman, Jonathan L.
Montefusco, Vittorio
Gavriatopoulou, Maria
Patriarca, Francesca
Omedé, Paola
Boise, Lawrence H.
Roussou, Maria
Giuliani, Nicola
Oliva, Stefania
Offidani, Massimo
Belotti, Angelo
Jaye, David L.
De Paoli, Lorenzo
Terpos, Evangelos
Lonial, Sagar
Boccadoro, Mario
Nooka, Ajay K.
Dimopoulos, Meletios A.
author_facet Mina, Roberto
Joseph, Nisha S.
Gay, Francesca
Kastritis, Efstathios
Petrucci, Maria Teresa
Kaufman, Jonathan L.
Montefusco, Vittorio
Gavriatopoulou, Maria
Patriarca, Francesca
Omedé, Paola
Boise, Lawrence H.
Roussou, Maria
Giuliani, Nicola
Oliva, Stefania
Offidani, Massimo
Belotti, Angelo
Jaye, David L.
De Paoli, Lorenzo
Terpos, Evangelos
Lonial, Sagar
Boccadoro, Mario
Nooka, Ajay K.
Dimopoulos, Meletios A.
author_sort Mina, Roberto
collection PubMed
description
format Online
Article
Text
id pubmed-7156404
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-71564042020-04-24 Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents Mina, Roberto Joseph, Nisha S. Gay, Francesca Kastritis, Efstathios Petrucci, Maria Teresa Kaufman, Jonathan L. Montefusco, Vittorio Gavriatopoulou, Maria Patriarca, Francesca Omedé, Paola Boise, Lawrence H. Roussou, Maria Giuliani, Nicola Oliva, Stefania Offidani, Massimo Belotti, Angelo Jaye, David L. De Paoli, Lorenzo Terpos, Evangelos Lonial, Sagar Boccadoro, Mario Nooka, Ajay K. Dimopoulos, Meletios A. Blood Cancer J Correspondence Nature Publishing Group UK 2020-04-14 /pmc/articles/PMC7156404/ /pubmed/32286263 http://dx.doi.org/10.1038/s41408-020-0307-4 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Mina, Roberto
Joseph, Nisha S.
Gay, Francesca
Kastritis, Efstathios
Petrucci, Maria Teresa
Kaufman, Jonathan L.
Montefusco, Vittorio
Gavriatopoulou, Maria
Patriarca, Francesca
Omedé, Paola
Boise, Lawrence H.
Roussou, Maria
Giuliani, Nicola
Oliva, Stefania
Offidani, Massimo
Belotti, Angelo
Jaye, David L.
De Paoli, Lorenzo
Terpos, Evangelos
Lonial, Sagar
Boccadoro, Mario
Nooka, Ajay K.
Dimopoulos, Meletios A.
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
title Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
title_full Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
title_fullStr Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
title_full_unstemmed Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
title_short Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
title_sort clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156404/
https://www.ncbi.nlm.nih.gov/pubmed/32286263
http://dx.doi.org/10.1038/s41408-020-0307-4
work_keys_str_mv AT minaroberto clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT josephnishas clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT gayfrancesca clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT kastritisefstathios clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT petruccimariateresa clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT kaufmanjonathanl clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT montefuscovittorio clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT gavriatopouloumaria clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT patriarcafrancesca clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT omedepaola clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT boiselawrenceh clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT roussoumaria clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT giulianinicola clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT olivastefania clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT offidanimassimo clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT belottiangelo clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT jayedavidl clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT depaolilorenzo clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT terposevangelos clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT lonialsagar clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT boccadoromario clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT nookaajayk clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents
AT dimopoulosmeletiosa clinicalfeaturesandsurvivalofmultiplemyelomapatientsharboringt1416intheeraofnovelagents